Other names: Rapivab
Categories: Prescription Medication
Description:
Peramivir (Rapivab) is an effective intravenous medication for treating acute uncomplicated influenza in patients aged 2 years and older.
Peramivir can reduce the duration of influenza symptoms. In adults, a single 600 mg dose of peramivir administered within 48 hours of symptom onset resulted in a median reduction of 21 hours in the time to alleviation of combined influenza symptoms compared to placebo. Additionally, the median time to recovery to normal temperature was approximately 12 hours sooner in the peramivir group compared to placebo.
Treatment For:
AI generated Summary: Based on the single review provided, Peramivir appears to be an effective treatment for influenza, receiving a rating of 4 out of 5. The review suggests that Peramivir is particularly useful when administered as a one-time intravenous dose, especially in cases where patient compliance with other treatment regimens may be a concern.
Peramivir is an intravenous one time dose antiviral medication used to treat influenza, especially if compliance is an issue.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
